GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » YoY EBITDA Growth

Qol Holdings Co (TSE:3034) YoY EBITDA Growth : -0.56% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Qol Holdings Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -0.56%.

Qol Holdings Co's EBITDA per Share for the three months ended in Dec. 2023 was 円78.79.


Qol Holdings Co YoY EBITDA Growth Historical Data

The historical data trend for Qol Holdings Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co YoY EBITDA Growth Chart

Qol Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.13 10.61 -5.13 27.30 -0.45

Qol Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 -4.75 8.93 -29.62 -0.56

Qol Holdings Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Qol Holdings Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(393.667-395.463)/ | 395.463 |
=-0.45 %

Qol Holdings Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(78.788-79.23)/ | 79.23 |
=-0.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qol Holdings Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Qol Holdings Co (TSE:3034) Business Description

Traded in Other Exchanges
N/A
Address
4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines